These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26349354)

  • 21. Glucocorticoid-induced osteoporosis and its treatment.
    Pennisi P; Trombetti A; Rizzoli R
    Clin Orthop Relat Res; 2006 Feb; 443():39-47. PubMed ID: 16462424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary and secondary prophylaxis to the use of inhaled glucocorticoid in primary health care.
    Nielsen BR; Jørgensen NR; Schwarz P
    J Asthma; 2008 Aug; 45(6):519-22. PubMed ID: 18612907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial.
    Curtis JR; Westfall AO; Allison J; Becker A; Melton ME; Freeman A; Kiefe CI; MacArthur M; Ockershausen T; Stewart E; Weissman N; Saag KG
    Arch Intern Med; 2007 Mar; 167(6):591-6. PubMed ID: 17389291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.
    Buckley L; Guyatt G; Fink HA; Cannon M; Grossman J; Hansen KE; Humphrey MB; Lane NE; Magrey M; Miller M; Morrison L; Rao M; Byun Robinson A; Saha S; Wolver S; Bannuru RR; Vaysbrot E; Osani M; Turgunbaev M; Miller AS; McAlindon T
    Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1095-1110. PubMed ID: 28585410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors.
    Bošković L; Gašparić M; Petković M; Gugić D; Lovasić IB; Soldić Ž; Miše BP; Dabelić N; Vazdar L; Vrdoljak E
    Breast; 2017 Feb; 31():16-19. PubMed ID: 27810693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
    Soen S
    Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corticosteroids: no drug prevention of fractures needed.
    Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cumulative network meta-analyses, practice guidelines, and actual prescriptions for postmenopausal osteoporosis: a meta-epidemiological study.
    Kataoka Y; Luo Y; Chaimani A; Onishi A; Kimachi M; Tsujimoto Y; Murad MH; Li T; Cipriani A; Furukawa TA
    Arch Osteoporos; 2020 Feb; 15(1):21. PubMed ID: 32088774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013.
    Compston J; Bowring C; Cooper A; Cooper C; Davies C; Francis R; Kanis JA; Marsh D; McCloskey EV; Reid DM; Selby P;
    Maturitas; 2013 Aug; 75(4):392-6. PubMed ID: 23810490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone safety of low-dose glucocorticoids in rheumatic diseases.
    Saag KG
    Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Secondary osteoporosis. Glucocorticoid induced osteoporosis in childhood : prophylaxis and treatment].
    Tanaka H
    Clin Calcium; 2007 Jul; 17(7):1114-9. PubMed ID: 17607080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.
    Bultink IE; Baden M; Lems WF
    Expert Opin Pharmacother; 2013 Feb; 14(2):185-97. PubMed ID: 23317448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An audit of osteoporotic patients in an Australian general practice.
    Parker D
    Aust Fam Physician; 2013 Jun; 42(6):423-7. PubMed ID: 23781552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Glucocorticoid induced osteoporosis in childhood: prophylaxis and treatment].
    Tanaka H
    Clin Calcium; 2009 Apr; 19(4):569-73. PubMed ID: 19329838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
    Ledwich LJ; Clarke K
    J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving trends in glucocorticoid-induced osteoporosis management: 2002 to 2006.
    Mohammad A; Ryan JG; Ralph N; Ryan C; O'Connell PG
    Clin Exp Rheumatol; 2007; 25(5):728-33. PubMed ID: 18078621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management and treatment of osteoporosis in patients receiving long-term glucocorticoid treatment: current status of adherence to clinical guidelines and related factors.
    Kirigaya D; Nakayama T; Ishizaki T; Ikeda S; Satoh T
    Intern Med; 2011; 50(22):2793-800. PubMed ID: 22082891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Guidelines on the management and treatment of glucocorticoid-induced osteoporosis (2004) in Japan].
    Takayanagi R
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():50-5. PubMed ID: 18161081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.